Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-FR | Version v1-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated | 2026-04-08 | 2026-04-08 |
| Drug Identification Number | 02247265 | 02247265 |
| Brand name | PENNSAID | PENNSAID |
| Common or Proper name | PENNSAID 1.5% SOL TOPI 60ML | PENNSAID 1.5% SOL TOPI 60ML |
| Company Name | KNIGHT THERAPEUTICS INC. | KNIGHT THERAPEUTICS INC. |
| Ingredients | DICLOFENAC SODIUM | DICLOFENAC SODIUM |
| Strength(s) | 1.5% | 1.5% |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | TOPICAL TOPICAL | TOPICAL TOPICAL |
| Packaging size | 60 mL | 60 mL |
| Additional packaging sizes | ||
| ATC code | M02AA | M02AA |
| ATC description | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| Reason for discontinuation | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2026-03-17 | 2026-03-17 |
| Remaining supply date | ||
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Discontinuation due to disruption of the manufacture of the drug | Discontinuation due to disruption of the manufacture of the drug |
| Health Canada comments |